Product Overview

4SC develops proprietary, small-molecule drugs against auto-immune and cancer indications. These indications have a large market need and 4SC is focused on developing compounds that have the potential to offer new benefits to patients and will generate value creating partnerships with pharmaceutical companies.

In addition to completing drug development, 4SC has a research division that is focused on generating novel, innovative potential drug candidates.  Research is an integral part of the 4SC's business strategy and ensures that promising clinical drug candidates continue to fill the company's drug pipeline.

(Click to enlarge)